Influenza (pandemic)

Task Force on Immunization in Africa

From the Task Force on Immunization (TIF) in Africa website:


Obituary: James Harlan Steele

Yesterday [10 Nov 2013], we all witnessed the exit of a lion.

Over his 100-year-plus lifespan, James Harlan Steele was a true pioneer in Public Health and the rebirth of One Health. He was tenacious in his quest to enlarge the role of veterinary medicine in public health, emboldened by the conviction that any avenue that can benefit the health and well-being of people leads to a more progressive, rational and fair state of affairs for his community, country, and the world.


Vaccin contre la grippe : entre méfiance et indifférence

La campagne 2013 de vaccination contre la grippe ne convainc pas, du moins pas autant. Seulement un tiers de la population se fera vacciner.


21st new human case of avian influenza H5N1 in Cambodia in 2013

The Ministry of Health (MoH) of the Kingdom of Cambodia wishes to advise members of the public that one new human case of avian influenza has been confirmed for the H5N1 virus. This is the 21st case this year and the 42nd person to become infected with the H5N1 virus in Cambodia. Of the 42 confirmed cases, 31 were children under 14, and 25 of the 42 were female. In addition, only 10 cases out of the 21 cases this year survived.


Five of the Most Terrible Epidemics That Won’t Happen Again (Thanks to Vaccines)

When I think of modern-day epidemics - HIV/AIDS, meningitis, threats of H7N9 - I find it easy to feel like we are helpless, sitting vulnerable to the whims of nature and viral mutation.

Southern Hemisphere flu drops as Northern Hemisphere's season starts

As the end of the Southern Hemisphere's flu season draws near, activity in Australia and New Zealand seems to have peaked, though over the last few weeks South Africa has seen a second, smaller peak, the World Health Organization (WHO) said today in a global flu update.

16th International Congress on Infectious Disease

Hosted by the International Society for Infectious Diseases:

Nanoparticle vaccine offers better protection: Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases

Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.


European prices reapply old pressures to vaccine makers

The vaccine sector appears to be in good health. After coming through a period in which low profit margins and liability concerns deterred investment, EvaluatePharma now tips the sector to grow from $25 billion to $39 billion between 2012 and 2018. Yet, in some areas, old complaints can still be heard.